Galectin Therapeutics Inc (GALT) Insider Trading
- $20,803,713.40
- $17,753,147.64
- Oct. 23, 2024
- Kevin D Freeman
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 23, 2024 | Director | 500 | $2.60 | Buy | $1,300.00 | |
Oct. 16, 2024 | Director | 5,000 | $2.70 | Buy | $13,500.00 | |
Aug. 23, 2024 | Director | 1,759 | $2.30 | Buy | $4,045.70 | |
April 30, 2024 | Director | 1,000 | $3.52 | Buy | $3,520.00 | |
April 24, 2024 | CEO | 1,000 | $3.39 | Buy | $3,390.00 | |
April 22, 2024 | Major Shareholder | 21,323 | $3.06 | Sell | $65,248.38 | |
April 22, 2024 | Director | 2,500 | $2.98 | Buy | $7,450.00 | |
Jan. 16, 2024 | Director | 500 | $1.79 | Buy | $895.00 | |
July 19, 2023 | Director | 1,598 | $1.79 | Buy | $2,860.42 | |
Feb. 21, 2023 | Director | 1,000 | $1.59 | Buy | $1,590.00 | |
Feb. 16, 2023 | CEO | 1,000 | $1.52 | Buy | $1,520.00 | |
Jan. 25, 2023 | Director | 1,300 | $1.11 | Buy | $1,443.00 | |
Nov. 17, 2022 | CFO | 4,000 | $1.32 | Buy | $5,280.00 | |
Oct. 28, 2022 | Director | 10,000 | $1.41 | Buy | $14,100.00 | |
July 28, 2022 | Director | 5,000 | $2.50 | Buy | $12,500.00 | |
May 19, 2022 | Director | 5,000 | $1.33 | Buy | $6,650.00 | |
April 18, 2022 | Director | 5,000 | $1.71 | Buy | $8,550.00 | |
April 4, 2022 | Director | 5,000 | $1.60 | Buy | $8,000.00 | |
Feb. 2, 2022 | Major Shareholder | 10,000 | $2.10 | Sell | $21,000.00 | |
Jan. 21, 2022 | Director | 1,000 | $2.00 | Buy | $2,000.00 | |
Jan. 19, 2022 | Director | 5,000 | $1.96 | Buy | $9,800.00 | |
Jan. 14, 2022 | Director | 5,000 | $2.02 | Buy | $10,100.00 | |
Jan. 11, 2022 | Major Shareholder | 10,000 | $2.10 | Sell | $21,000.00 | |
Dec. 6, 2021 | Director | 5,000 | $2.34 | Buy | $11,700.00 | |
Dec. 2, 2021 | Major Shareholder | 10,000 | $2.37 | Sell | $23,700.00 | |
Nov. 1, 2021 | Major Shareholder | 10,000 | $3.19 | Sell | $31,900.00 | |
Oct. 29, 2021 | Director | 2,000 | $3.17 | Buy | $6,340.00 | |
Oct. 21, 2021 | Director | 2,000 | $3.19 | Buy | $6,380.00 | |
Oct. 19, 2021 | Director | 3,000 | $3.37 | Buy | $10,110.00 | |
Oct. 15, 2021 | Major Shareholder | 10,000 | $3.37 | Sell | $33,700.00 | |
Oct. 4, 2021 | Major Shareholder | 10,000 | $3.62 | Sell | $36,200.00 | |
Sept. 23, 2021 | Director | 3,000 | $3.88 | Buy | $11,640.00 | |
Sept. 1, 2021 | Major Shareholder | 10,000 | $3.91 | Sell | $39,100.00 | |
Aug. 2, 2021 | Major Shareholder | 10,000 | $3.25 | Sell | $32,500.00 | |
July 9, 2021 | Major Shareholder | 10,000 | $3.54 | Sell | $35,400.00 | |
May 3, 2021 | Major Shareholder | 27,500 | $3.97 | Sell | $109,175.00 | |
April 5, 2021 | Director | 5,000 | $2.04 | Buy | $10,200.00 | |
April 1, 2021 | Major Shareholder | 10,000 | $2.16 | Sell | $21,600.00 | |
Feb. 2, 2021 | Major Shareholder | 10,000 | $2.04 | Sell | $20,400.00 | |
Jan. 11, 2021 | Director | 60,000 | $2.17 | Sell | $130,200.00 | |
Oct. 13, 2020 | Major Shareholder | 10,000 | $2.97 | Sell | $29,700.00 | |
Sept. 4, 2020 | Director | 5,000 | $2.57 | Buy | $12,850.00 | |
March 19, 2020 | Director | 6,000 | $1.69 | Buy | $10,140.00 | |
Jan. 17, 2020 | Major Shareholder | 10,000 | $2.97 | Sell | $29,700.00 | |
Nov. 15, 2019 | Director | 3,000 | $3.36 | Buy | $10,080.00 | |
Oct. 10, 2019 | Major Shareholder | 17,000 | $3.73 | Sell | $63,410.00 | |
Sept. 6, 2019 | Director | 1,290 | $3.71 | Buy | $4,785.90 | |
May 31, 2019 | CFO | 2,354 | $4.28 | Buy | $10,075.12 | |
May 31, 2019 | Director | 4,680,606 | $4.28 | Buy | $20,032,993.68 | |
April 9, 2019 | Director | 20,700 | $4.82 | Buy | $99,774.00 |
Insiders are both buying and selling Galectin Therapeutics Inc stock.
The insider traders at Galectin Therapeutics Inc are: Kevin D Freeman, Fund L.P. 10X, Peter G Traber, Jack W Callicutt, James C Czirr, Kary Eldred, Marc Rubin, Richard A Jr. Zordani, Harold H Shlevin, Joel Lewis, Richard E Uihlein, Arthur Greenberg, Theodore Daniel Zucconi, Gilbert F Amelio, Gilbert S Omenn, John F Mauldin, Steven Prelack, and Elissa J Schwartz
The most active insider trader at Galectin Therapeutics Inc is Kevin D Freeman with 22 trades.
James C Czirr has sold the most Galectin Therapeutics Inc stock with a total value of $5,546,368.61.
Richard E Uihlein has bought the most Galectin Therapeutics Inc stock with a total value of $40,416,566.36.
The most recent insider trade for Galectin Therapeutics Inc was on Oct. 23, 2024.
The single biggest insider buy for Galectin Therapeutics Inc was from Richard E Uihlein with a total value of $20,032,993.68 on May 31, 2019.
The single biggest insider sell for Galectin Therapeutics Inc was from Jack W Callicutt with a total value of $1,945,860.00 on June 20, 2018.